Spero Therapeutics, Inc.
Pharmaceutical Preparations · Cambridge, MA, United States
- PrincipalsTimothy KeutzerChief Operating Officerand 1 more
- CompanySpero Therapeutics, Inc.Cambridge, MA, United States
- Phone line+1 (857) 242-1600General business
Spero Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker SPRO) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 2
Operations
Timothy KeutzerChief Operating Officer
Everyone else on file (1)
Esther RajaveluOfficer (see SEC filing)
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Timothy Keutzer — Chief Operating Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Esther Rajavelu — Officer (see SEC filing)
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Mereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilitySilence Therapeutics plcPharmaceutical Preparations · London1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityRoivant Sciences Ltd.Pharmaceutical Preparations · London1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityTeva Pharmaceutical Industries LtdPharmaceutical Preparations · Tel Aviv1 shared capabilityAmneal Pharmaceuticals, Inc.Pharmaceutical Preparations1 shared capability